Clinical trial
Effect of Transdermal Glyceryl-Trinitrate and Parecoxib (Valdecoxib) for the Prevention of Post -ERCP Pancreatitis
NCT00419549 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Transdermal Glyceryl-Trinitrate and Parecoxib (Valdecoxib) for the Prevention of Post -ERCP Pancreatitis
- Lead sponsor
- All India Institute of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- October 31, 2003
- Completion date
- September 30, 2005
- Enrollment
- 371 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ercp, pancreatitis